このレポートは、現在のサプライヤーと潜在的な市場参入者が、今後5年間に分子診断市場で出現する主要なビジネス チャンスを特定し、評価するのに役立つように設計されています。レポートはセクション別に提供されており、特定の情報ニーズと予算に合わせてカスタマイズできます。
分子診断市場は、疑いなく体外診断業界で最も急速に成長している分野です。今後 5 年間は、試薬システムと自動化の大きな進歩、そして革新的なマーケティング手法を必要とする幅広い新製品の導入が見られるでしょう。ただし、日常的な臨床検査室への市場浸透率は、増幅法を備えた費用対効果の高い自動化システムの導入にかかっています。
分子診断市場がもたらす機会をうまく活用するために、多くの企業がすでに新しい分子技術を企業戦略資産として活用し、ビジネスおよびマーケティング戦略をサポートする形で管理しています。新しい技術計画をビジネスおよび企業戦略と統合することは、今後5年間で診断企業にとって最も困難な課題の1つとなるでしょう。
オーストラリア、バングラデシュ、中国、香港、インド、インドネシア、日本、マレーシア、ミャンマー、ニュージーランド、パキスタン、フィリピン、シンガポール、韓国、台湾、タイ、トルコ、ベトナム
目次
Table of Contents
I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
B. DNA and RNA Probe Technologies
C. Detection Technologies
D. Instrumentation
Review of latest analyzers from Abbott, Beckman Coulter/Danaher, Becton Dickinson,
bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and other suppliers.
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
- AIDS/HIV
- Adenovirus
- Aeromonads
- Anthrax/Bacillus Anthracis
- Arboviruses
- Babesiosis
- Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
- Blastocystis Hominis
- Brucella
- Campylobacter
- Candida
- Chagas Disease
- Chancroid
- Chlamydia
- Clostridium Difficile
- Coronaviruses
- Coxsackieviruses
- Creutzfeldt-Jakob’s Disease
- Cryptosporidium Parvum
- Cyclospora Cayetanensis
- Cytomegalovirus
- Ebola Virus
- E. Coli
- EchoVirus
- Encephalitis
- Enteroviruses
- Epstein-Barr Virus
- Giardia Lamblia
- Gonorrhea
- Granuloma Inguinale
- Hantavirus
- Helicobacter Pylori
- Hepatitis
- Herpes Simplex Virus
- Human Herpes Virus-6 (HHV-6)
- Influenza Viruses
- Legionella
- Lyme Disease
- Lymphogranuloma Venereum (LGV)
- Malaria
- Measles (Rubeola)
- Meningitis
- Microsporidium
- Mononucleosis
- Mumps
- Mycoplasma
- Papillomaviruses
- Parvovirus B19
- Pneumonia
- Polyomaviruses
- Pseudomonas Aeruginosa
- Rabies
- Respiratory Syncytial Virus (RSV)
- Rhinoviruses
- Rotavirus
- Rubella
- Salmonellosis
- Septicemia
- Shigellosis
- Staphylococcus Aureus
- Streptococci
- Syphilis
- Toxoplasmosis
- Trichomonas Vaginalis
- Tuberculosis
- Vibrio
- West Nile Virus
- Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
- Prostate
- Lung
- Colon and Rectum
- Breast
- Skin
- Uterine
- Leukemia
- Oral
c. Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
- Achondroplasia
- Autosomal Dominant Polycystic Kidney Disease
- Cancer
- Cosmetogenomics
- Cystic Fibrosis
- Down's Syndrome
- Duchenne and Becker Muscular Dystrophy
- Factor V (Leiden)
- Factor IX Deficiency
- Fragile X Syndrome
- Heart Disease
- Hemochomatosis
- Hemophilia
- Huntington's Disease
- Maternal-Fetal Incompatibility
- Multiple Endocrine Neoplasia
- Phenylketonuria (PKU)
- Polycystic Kidney Disease (PKD)
- Prenatal Screening
- Retinitis Pigmentosa
- Retinoblastoma
- Sickle Cell Anemia
- Spinal Muscular Atrophy
- Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
c. DNA Profile Data Banks
d. Judicial Implementation
e. Major Crime Categories
f. Factors Contributing to the DNA Probe Market Expansion
- Technology Availability
- Use of Hair as Evidence
g. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/Complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
I. Country Analyses: Volume and Sales Forecasts--Infectious Diseases, Genetic Diseases,
Cancer, Forensic and Paternity Testing
- Australia
- Bangladesh
- China
- Hong Kong
- India
- Indonesia
- Japan
- Malaysia
- Myanmar
- New Zealand
- Pakistan
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
J. Competitive Assessments
The report provides strategic assessments of over 40 leading molecular diagnostics market players
and start-up companies with innovative technologies and products, including:
Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad,
Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom,
Leica Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel,
Roche, Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher,
Wako and others.
VII. Appendix: Major Universities and Research Centers Developing Innovative
Molecular Diagnostic Technologies and Products
List of Tables
Australia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Australia
Molecular Diagnostics Test Volume Forecasts by Application
Australia
Major Infectious Disease Test Volume Forecasts by Assay
Australia
Molecular Diagnostics Market Forecasts by Application
Australia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Australia
Major Supplier Sales and Market Shares
Bangladesh
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Bangladesh
Molecular Diagnostics Test Volume Forecasts by Application
Bangladesh
Major Infectious Disease Test Volume Forecasts by Assay
Bangladesh
Molecular Diagnostics Market Forecasts by Application
Bangladesh
Major Infectious Disease Diagnostics Market Forecasts by Assay
Bangladesh
Major Supplier Sales and Market Shares
China
Molecular Diagnostics Test Volume and Sales Forecasts by Application
China
Molecular Diagnostics Test Volume Forecasts by Application
China
Major Infectious Disease Test Volume Forecasts by Assay
China
Molecular Diagnostics Market Forecasts by Application
China
Major Infectious Disease Diagnostics Market Forecasts by Assay
China
Major Supplier Sales and Market Shares
Hong Kong
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Hong Kong
Molecular Diagnostics Test Volume Forecasts by Application
Hong Kong
Major Infectious Disease Test Volume Forecasts by Assay
Hong Kong
Molecular Diagnostics Market Forecasts by Application
Hong Kong
Major Infectious Disease Diagnostics Market Forecasts by Assay
Hong Kong
Major Supplier Sales and Market Shares
India
Molecular Diagnostics Test Volume and Sales Forecasts by Application
India
Molecular Diagnostics Test Volume Forecasts by Application
India
Major Infectious Disease Test Volume Forecasts by Assay
India
Molecular Diagnostics Market Forecasts by Application
India
Major Infectious Disease Diagnostics Market Forecasts by Assay
India
Major Supplier Sales and Market Shares
Indonesia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Indonesia
Molecular Diagnostics Test Volume Forecasts by Application
Indonesia
Major Infectious Disease Test Volume Forecasts by Assay
Indonesia
Molecular Diagnostics Market Forecasts by Application
Indonesia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Indonesia
Major Supplier Sales and Market Shares
Japan
Molecular Diagnostics Test Volume and Sales by Major Application
Japan
Laboratories Performing DNA Sequencing by Market Segment
Japan
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
Japan
Molecular Diagnostics Test Volume by Major Application
Japan
Major Infectious Disease Test Volume by Assay
Japan
Major Infectious Disease Test Volume by Method
Japan
Molecular Diagnostics Market by Major Application
Japan
Molecular Diagnostics Market
Estimated Sales and Market Shares of Major Suppliers
Japan
Major Infectious Disease Diagnostics Market by Assay
Japan
AIDS Testing Market Estimated Sales by Major Supplier
Japan
Chlamydia Testing Market Estimated Sales by Major Supplier
Japan
CMV Testing Market Estimated Sales by Major Supplier
Japan
Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis Testing Market Estimated Sales by Major Supplier
Japan
Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan
Herpes Testing Market Estimated Sales by Major Supplier
Japan
Meningitis Testing Market Estimated Sales by Major Supplier
Japan
Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan
Pneumonia Testing Market Estimated Sales by Major Supplier
Japan
Shigella Testing Market Estimated Sales by Major Supplier
Malaysia
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Malaysia
Molecular Diagnostics Test Volume Forecasts by Application
Malaysia
Major Infectious Disease Test Volume Forecasts by Assay
Malaysia
Molecular Diagnostics Market Forecasts by Application
Malaysia
Major Infectious Disease Diagnostics Market Forecasts by Assay
Malaysia
Major Supplier Sales and Market Shares
Myanmar
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Myanmar
Molecular Diagnostics Test Volume Forecasts by Application
Myanmar
Major Infectious Disease Test Volume Forecasts by Assay
Myanmar
Molecular Diagnostics Market Forecasts by Application
Myanmar
Major Infectious Disease Diagnostics Market Forecasts by Assay
Myanmar
Major Supplier Sales and Market Shares
New Zealand
Molecular Diagnostics Test Volume and Sales Forecasts by Application
New Zealand
Molecular Diagnostics Test Volume Forecasts by Application
New Zealand
Major Infectious Disease Test Volume Forecasts by Assay
New Zealand
Molecular Diagnostics Market Forecasts by Application
New Zealand
Major Infectious Disease Diagnostics Market Forecasts by Assay
New Zealand
Major Supplier Sales and Market Shares
Pakistan
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Pakistan
Molecular Diagnostics Test Volume Forecasts by Application
Pakistan
Major Infectious Disease Test Volume Forecasts by Assay
Pakistan
Molecular Diagnostics Market Forecasts by Application
Pakistan
Major Infectious Disease Diagnostics Market Forecasts by Assay
Pakistan
Major Supplier Sales and Market Shares
Philippines
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Philippines
Molecular Diagnostics Test Volume Forecasts by Application
Philippines
Major Infectious Disease Test Volume Forecasts by Assay
Philippines
Molecular Diagnostics Market Forecasts by Application
Philippines
Major Infectious Disease Diagnostics Market Forecasts by Assay
Philippines
Major Supplier Sales and Market Shares
Singapore
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Singapore
Molecular Diagnostics Test Volume Forecasts by Application
Singapore
Major Infectious Disease Test Volume Forecasts by Assay
Singapore
Molecular Diagnostics Market Forecasts by Application
Singapore
Major Infectious Disease Diagnostics Market Forecasts by Assay
Singapore
Major Supplier Sales and Market Shares
South Korea
Molecular Diagnostics Test Volume and Sales Forecasts by Application
South Korea
Molecular Diagnostics Test Volume Forecasts by Application
South Korea
Major Infectious Disease Test Volume Forecasts by Assay
South Korea
Molecular Diagnostics Market Forecasts by Application
South Korea
Major Infectious Disease Diagnostics Market Forecasts by Assay
South Korea
Major Supplier Sales and Market Shares
Taiwan
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Taiwan
Molecular Diagnostics Test Volume Forecasts by Application
Taiwan
Major Infectious Disease Test Volume Forecasts by Assay
Taiwan
Molecular Diagnostics Market Forecasts by Application
Taiwan
Major Infectious Disease Diagnostics Market Forecasts by Assay
Taiwan
Major Supplier Sales and Market Shares
Thailand
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Thailand
Molecular Diagnostics Test Volume Forecasts by Application
Thailand
Major Infectious Disease Test Volume Forecasts by Assay
Thailand
Molecular Diagnostics Market Forecasts by Application
Thailand
Major Infectious Disease Diagnostics Market Forecasts by Assay
Thailand
Major Supplier Sales and Market Shares
Vietnam
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Vietnam
Molecular Diagnostics Test Volume Forecasts by Application
Vietnam
Major Infectious Disease Test Volume Forecasts by Assay
Vietnam
Molecular Diagnostics Market Forecasts by Application
Vietnam
Major Infectious Disease Diagnostics Market Forecasts by Assay
Vietnam
Major Supplier Sales and Market Shares
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests for Genetic Diseases